Compare AOUT & BWAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AOUT | BWAY |
|---|---|---|
| Founded | 2020 | 2003 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Ordnance And Accessories | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 152.9M | 578.5M |
| IPO Year | 2020 | 2011 |
| Metric | AOUT | BWAY |
|---|---|---|
| Price | $15.68 | $13.93 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 2 |
| Target Price | $12.50 | ★ $13.25 |
| AVG Volume (30 Days) | ★ 285.4K | 107.3K |
| Earning Date | 03-12-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $190,536,000.00 | N/A |
| Revenue This Year | N/A | $309.69 |
| Revenue Next Year | $8.06 | $26.21 |
| P/E Ratio | ★ N/A | $81.98 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $6.26 | $11.77 |
| 52 Week High | $16.09 | $26.63 |
| Indicator | AOUT | BWAY |
|---|---|---|
| Relative Strength Index (RSI) | 73.02 | 40.31 |
| Support Level | $7.84 | $11.90 |
| Resistance Level | N/A | $14.83 |
| Average True Range (ATR) | 0.80 | 0.47 |
| MACD | 0.57 | -0.04 |
| Stochastic Oscillator | 85.33 | 3.85 |
American Outdoor Brands Inc is the provider of outdoor lifestyle products and shooting sports accessories encompassing hunting, fishing, meat processing, outdoor cooking, shooting, and personal security and defense products for rugged outdoor enthusiasts. It conceive, design, produce or source, and sell its outdoor lifestyle products including premium sportsman knives, land management tools, products used while hunting, meat processing equipment; and outdoor cooking products and hooting sports accessories, including rests, vaults, and other related accessories, electro-optical devices, including hunting optics, firearm aiming devices, flashlights, and laser grips, etc. The company operate as one reporting segment.
BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.